Vimarsana
Biggest News Aggregation in the World

Page 31 - Medication Guide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medication Guide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medication Guide Today - Breaking & Trending Today

Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) - Vimarsana News

Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

COPENHAGEN, Denmark--(BUSINESS WIRE)--Jul 21, 2023--

Long Term Phase 3 Data Published in Arthritis & Rheumatology Shows LUPKYNIS® (voclosporin) Preserved Kidney Function Up to Three Years in Lupus Nephritis Patients with No New or Unexpected Adverse Events - Vimarsana News

Long Term Phase 3 Data Published in Arthritis & Rheumatology Shows LUPKYNIS® (voclosporin) Preserved Kidney Function Up to Three Years in Lupus Nephritis Patients with No New or Unexpected Adverse Events

Aurinia Pharmaceuticals Inc. today announced that full results from the Phase 3, double-blind, placebo-controlled AURORA 2 extension study were published online in Arthritis & Rheumatology, the...

Dr. Muneeb Shah Prioritizes Authenticity and Transparency on Social Media - Vimarsana News

Dr. Muneeb Shah Prioritizes Authenticity and Transparency on Social Media

During a panel hosted by Allē, the Allergan Aesthetics loyalty program, the content creator discussed educating his audience on social media

Olivia Culpo, Bobby Berk, Dr. Muneeb Shah and Felicia Walker Openly Discuss Aesthetic Treatments - Vimarsana News

Olivia Culpo, Bobby Berk, Dr. Muneeb Shah and Felicia Walker Openly Discuss Aesthetic Treatments

During a conversation hosted by Allē, the aesthetics/lifestyle experts and content creators known for authenticity discussed the growing push for honesty on social media

Incyte Announces Positive Topline Results from Phase 3 Trial Evaluating Ruxolitinib Cream (Opzelura®) in Children with Atopic Dermatitis - Vimarsana News

Incyte Announces Positive Topline Results from Phase 3 Trial Evaluating Ruxolitinib Cream (Opzelura®) in Children with Atopic Dermatitis

Phase 3 TruE-AD3 Study met its primary endpoint